Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle‐aged or elderly people
Year: 2017
Type: article
Study design: Observational Study
Abstract: Introduction It is hypothesized that cerebral hypoperfusion promotes the development of Alzheimer pathology. We therefore studied whether longstanding cerebral hypoperfusion is associated with Alzheimer pathology in nondemented humans. Methods Cerebral blood flow and amyloid β (18F‐Flutemetamol) positron emission tomography retention were assessed in eleven patients with unilateral occlusion of precerebral arteries resulting in chronic and uneven hypoperfusion. A subset of patients underwent tau (18F‐AV‐1451) positron emission tomography. Results The blood flow was significantly reduced on the affected side of the brain in patients with unilateral occlusion of the internal carotid artery or stenosis of the middle cerebral artery. However, the cortical uptake of 18F‐Flutemetamol or 18F‐AV‐1451 was not altered. Discussion Our results suggest that longstanding cerebral hypoperfusion in humans does not result in accumulation of amyloid β fibrils or tau aggregates.
Source: Alzheimer s & Dementia
Institutions: Lund University, Skåne University Hospital
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,200
Funders: Eli Lilly and Company, Torsten Söderbergs Stiftelse, Australian Government, Marcus Foundation, Fondation pour la Recherche Médicale, Lunds Universitet, Hjärnfonden, Vetenskapsrådet, Greta och Johan Kocks stiftelser, Marcus och Amalia Wallenbergs minnesfond, Stiftelsen Bundy Academy, Avid Radiopharmaceuticals, H2020 European Research Council
Award: G6870540333
OpenAlex ID: W2735975108
